Summary of the National Advisory Committee on Immunization (NACI) statement on the prevention of respiratory syncytial virus (RSV) in older adults
Based on available evidence, NACI recommends RSV immunization programs for adults 75 years of age and older, particularly for older adults with chronic health conditions who are at increased risk of severe RSV disease. NACI also recommends RSV immunization programs for adults 60 years of age and older who are residents of nursing homes and other chronic care facilities. NACI recommends that receiving an RSV vaccine may be considered as an individual decision by adults 50 to 74 years of age, in consultation with their healthcare provider.
Authors
- Winnie Siu (ORCID: https://orcid.org/0009-0001-5772-1509)
- Elissa M. Abrams (ORCID: https://orcid.org/0000-0003-3433-1986)
- April Killikelly
- Nicholas Brousseau (ORCID: https://orcid.org/0000-0001-6042-3177)
Institutions
- Manitoba Health (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- Public Health Agency of Canada (CA)
- Centre de Médecine Préventive (FR)
- Université Laval (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2025-08-28
- DOI
- https://doi.org/10.14745/ccdr.v51i08a01
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Public Health Agency of Canada
- Public Health Agency
- Indigenous Services Canada
- Centers for Disease Control and Prevention